Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

5030 total record number 58 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 8 out of 35
341 citations found

BPTES inhibits anthrax lethal toxin-induced inflammatory response

Wang, J;Yang, D;Shen, X;Wang, J;Liu, X;Lin, J;Zhong, J;Zhao, Y;Qi, Z;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Ligand Binding to the Collagen VI Receptor Triggers a Talin-to-RhoA Switch that Regulates Receptor Endocytosis

Brgi, J;Abrami, L;Castanon, I;Abriata, LA;Kunz, B;Yan, SE;Lera, M;Unger, S;Superti-Furga, A;Peraro, MD;Gaitan, MG;van der Goot, FG;

Product: Anti-Protective Antigen from B. anthracis (Goat)

  • Anthrax Protective Antigen List Biologicals Ref: 771B

Platelets Fuel the Inflammasome Activation of Innate Immune Cells

Rolfes, V;Ribeiro, LS;Hawwari, I;Bttcher, L;Rosero, N;Maasewerd, S;Santos, MLS;Prchnicki, T;Silva, CMS;Wanderley, CWS;Rothe, M;Schmidt, SV;Stunden, HJ;Bertheloot, D;Rivas, MN;Fontes, CJ;Carvalho, LH;Cunha, FQ;Latz, E;Arditi, M;Franklin, BS;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

  • Chemicals, Peptides, and Recombinant Proteins

    Protective antigen (PA), recombinant from Bacillus anthracis List Biological Laboratories 171C

    Stimulation assays

    … For the stimulation of the NLRC4 inflammasome, human macrophages were primed with 200 ng ml-1 LPS for 3 hours before 2 μg ml-1 LFn-PrgI and 0.5 μg ml-1 PA (from Bacillus anthracis) were added to the culture medium for 2 hours (Zhao et al., 2011).

    Product #171E – Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Toxin-neutralizing antibodies elicited by naturally acquired cutaneous anthrax are elevated following severe disease and appear to target conformational epitopes

Dumas, EK;Demiraslan, H;Ingram, RJ;Sparks, RM;Muns, E;Zamora, A;Larabee, J;Garman, L;Ballard, JD;Boons, GJ;James, JA;Kayabas, U;Doganay, M;Farris, AD;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

An Apoptotic Caspase Network Safeguards Cell Death Induction in Pyroptotic Macrophages

de Vasconcelos, N;Van Opdenbosch, N;Van Gorp, H;Martn-Prez, R;Zecchin, A;Vandenabeele, P;Lamkanfi, M;

Product: Anthrax Lethal Factor (LF), Recombinant from B. anthracis

Specific Detection of Anthrax Infection

Shine, N.; Suryadi, K.

Product: Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence

  • Materials and Methods

    Anthrax lethal factor, Product #169 and MAPKKide® Plus, Prod #532 are from List Biological Laboratories,
    Inc.
    The 96-well, black, flat bottom, nonbinding plates used for the fluorescent plate assay were from
    Corning (cat # 3991). The filtered adult bovine plasmas: Na-Citrate, cat #7310806; K2-EDTA, cat #7310807;
    K3-EDTA, cat #7310808; Li-Heparin, cat #7310810 ; Na-Heparin, cat #7310811; and the filtered adult bovine
    serum cat #7330800 were purchased from Lampire Biological Laboratories.

    Sample Preparation: Stock solutions of the fluorogenic substrate, MAPKKide® Plus, were made 1.25 mM
    in DMSO. The substrate was then diluted 5-fold to 250 µM in assay buffer: 20 mM HEPES, pH 8.0 containing
    0.1% Tween-20.

    LF Activity Assay: LF was spiked into each plasma or serum sample and then each was diluted 1:5 using
    assay buffer. The reaction was initiated by addition of 10 μM MAPKKide® Plus directly to the 1:5 diluted
    plasma or serum, and the assays were run at 37°C using the kinetic mode of the plate reader with readings
    at 1-minute intervals. The samples were run in triplicate with 9 replicate blanks. The limit of detection was
    calculated from the normal distribution of the blank samples (mean + 3 stdev; n = 3 triplicates).

    Product #169L – Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence
    Product #532 – MAPKKide® Plus (AMC) Specific Substrate for Anthrax Lethal Factor

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Anthrax Toxin as a Molecular Platform to Target Nociceptive Neurons and Modulate Pain

Yang, NJ;Isensee, J;Neel, D;Liu, SM;Zhang, HXB;

Product: Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence

Cryo-EM structure of the fully-loaded asymmetric anthrax lethal toxin in its heptameric pre-pore state

Antoni, C;Quentin, D;Lang, AE;Aktories, K;

Product: Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence

  • Protein expression and purification

    Upon addition of double molar excess of trypsin inhibitor (Sigma Aldrich), PA7 was further purified by size exclusion chromatography using a Superdex 200 column (GE Healthcare). Lyophilized LF (List Biological Lab. Inc., Lot#1692A1B) were resuspended in water according to the manufacturer’s manual and mixed with PA7 in a molar ration of 10:1. …

    Product #169L – Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence

Eicosapentaenoic acid prevents inflammation induced by acute cerebral infarction through inhibition of NLRP3 inflammasome activation

Mo, Z;Tang, C;Li, H;Lei, J;Zhu, L;Kou, L;Li, H;Luo, S;Li, C;Chen, W;Zhang, L;

Product: Anthrax Lethal Factor (LF), Recombinant from B. anthracis